Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | CA12 | O43570 | 4/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17923943 | 0.89 | TSHR (0.42) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL17923972 | 0.82 | TSHR (0.36) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL17923970 | 0.80 | TSHR (0.42) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL29846315 | 0.80 | TSHR (0.42) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL17923875 | 0.80 | GAA (0.41) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL18127545 | 0.79 | TSHR (0.39) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL18127556 | 0.79 | TSHR (0.39) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL17923995 | 0.79 | TSHR (0.35) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL17469812 | 0.78 | TSHR (0.43) | TSHRCA12CA14CA7CA9 | |
| SCHEMBL18127535 | 0.77 | TSHR (0.41) | TSHRCA12CA14CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4191727-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND POWER STORAGE DEVICE USING SAME | MU IONIC SOLUTIONS CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260112701-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | MU IONIC SOLUTIONS CORPORATION (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4708437-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | MU Ionic Solutions Corporation (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-12500271-B2 | Non-aqueous electrolyte solution and power storage device using same | MU IONIC SOLUTIONS CORPORATION (JP) | 2025-12-16 | — | — | US | disclosed |
| US-12159967-B2 | Nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-12-03 | — | — | US | disclosed |
| WO-2024228316-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | ＭＵアイオニックソリューションズ株式会社 | 2024-11-07 | — | — | WO | disclosed |
| EP-4030524-B1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-4318719-A2 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20230343990-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-11784342-B2 | Nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20180034105-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3273520-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE SECONDARY CELL IN WHICH SAME IS USED | Mitsubishi Chemical Corporation (JP) | 2018-01-24 | — | — | EP | disclosed |
| EP-3252861-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION, AND NON-AQUEOUS-ELECTROLYTE SECONDARY CELL USING SAME | Mitsubishi Chemical Corporation (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-3098893-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | MITSUBISHI CHEM CORP (JP) | 2017-11-29 | — | — | EP | disclosed |
| US-20170324116-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-11-09 | — | — | US | disclosed |
| EP-3098893-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING SAME | Mitsubishi Chemical Corporation (JP) | 2016-11-30 | — | — | EP | disclosed |
| US-20160322669-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| US-9461334-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-10-04 | — | — | US | disclosed |
| EP-3051618-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | Mitsubishi Chemical Corporation (JP) | 2016-08-03 | — | — | EP | disclosed |
| US-20160211553-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260112701-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION | NHERF1, SLC9A2, SCNN1B | TSHR 3995/4885CA12 233/4885CA14 657/4885 |
| US-20170324116-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND NON-AQUEOUS ELECTROLYTE SOLUTION SECONDARY BATTERY USING THE SAME | KCNN2, KCNE1, KCNN1 | TSHR 3439/4885CA12 88/4885CA14 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.